Paper Details
- Home
- Paper Details
Original Abstract of the Article :
In a prospective, open clinical trial 21 patients suffering from lower respiratory tract infections were treated with the new oral cephalosporin cefixime. The antibiotic was given at a dosage of 200 mg b. i. d. for seven to eleven days. Seventeen of 18 evaluable patients were cured or distinctly imp...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1007/BF01644628
データ提供：米国国立医学図書館（NLM）
Cefixime: A Refreshing Oasis in the Desert of Lower Respiratory Tract Infections
The landscape of [lower respiratory tract infections] is a vast and often unforgiving desert, where many find themselves struggling to combat the onslaught of bacteria. This research, much like a refreshing oasis in the midst of this arid landscape, explores the effectiveness of [cefixime] in treating these infections. The study, conducted as a [prospective, open clinical trial], aimed to determine whether this antibiotic could effectively combat the bacteria responsible for these infections. The researchers assessed the [clinical and bacteriological responses] of patients treated with cefixime, evaluating its efficacy and tolerability in this challenging setting.
An Oasis of Relief in the Desert of Infection
The study found that [cefixime was effective in treating lower respiratory tract infections], offering relief to those suffering from these debilitating ailments. The fact that [most patients experienced clinical improvement and eradication of the infecting pathogens] is a testament to the antibiotic's effectiveness. This finding is like discovering a hidden oasis in the desert, offering hope for a new path forward in the fight against these infections.
Navigating the Desert of Infection with Cefixime
This research offers a beacon of hope in the desert of lower respiratory tract infections. The potential of cefixime to effectively combat bacterial infections represents a significant breakthrough. Just as a camel relies on its adaptations to survive in the desert, we must continue to seek new solutions to combat these challenging infections.
Dr.Camel's Conclusion
This research provides evidence for the effectiveness of cefixime in treating lower respiratory tract infections. The study's findings suggest that cefixime is a valuable tool in the fight against these infections. Like a camel navigating the shifting sands of the desert, researchers continue to adapt and seek new solutions to combat these challenging infections.
Date :
- Date Completed 1991-05-01
- Date Revised 2019-08-28
Further Info :
Related Literature
German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.